Behavioral alterations and Fos protein immunoreactivity in brain regions of bile duct-ligated cirrhotic rats by Le Sueur-Maluf, Luciana et al.
An Acad Bras Cienc (2015) 87 (1)
Anais da Academia Brasileira de Ciências (2015) 87(1):
(Annals of the Brazilian Academy of Sciences)
Printed version ISSN 0001-3765 / Online version ISSN 1678-2690
www.scielo.br/aabc
331-341
http://dx.doi.org/10.1590/0001-3765201420130262
Behavioral alterations and Fos protein immunoreactivity 
in brain regions of bile duct-ligated cirrhotic rats
LUCIANA LE SUEUR-MALUF1, MILENA B. VIANA1, MÁRCIA R. NAGAOKA1, 
ANA LAURA B. AMORIM1, AMANDA N. CARDOSO1, BRUNA C. RODRIGUES1, 
NATÁLIA F. MENDES1, JACKSON C. BITTENCOURT2 and ISABEL C. CÉSPEDES1
1Departamento de Biociências, Universidade Federal de São Paulo/UNIFESP, 
Rua Silva Jardim, 136, 11015-020 Santos, SP, Brasil
2Laboratório de Neuroanatomia Química, Departamento de Anatomia, Instituto de Ciências Biomédicas, 
Universidade de São Paulo/USP, Av. Prof Lineu Prestes, 2415, 05508-900 São Paulo, SP, Brasil
Manuscript received on July 25, 2013; accepted for publication on August 24, 2014
ABSTRACT
Hepatic encephalopathy (HE) encompasses a variety of neuropsychiatric symptoms, including anxiety and 
psychomotor dysfunction. Although HE is a frequent complication of liver cirrhosis, the neurobiological 
substrates responsible for its clinical manifestations are largely unclear. In the present study, male Wistar rats 
were bile duct-ligated (BDL), a procedure which induces liver cirrhosis, and on the 21st day after surgery 
tested in the elevated plus-maze (EPM) and in an open field for anxiety and locomotor activity measurements. 
Analysis of Fos protein immunoreactivity (Fos-ir) was used to better understand the neurobiological alterations 
present in BDL animals. Plasma levels of ammonia were quantified and histopathological analysis of the 
livers was performed. BDL rats showed a significant decrease in the percentage of entries and time spent in 
the open arms of the EPM, an anxiogenic effect. These animals also presented significant decreases in Fos-ir 
in the lateral septal nucleus and medial amygdalar nucleus. Their ammonia plasma levels were significantly 
higher when compared to the sham group and the diagnosis of cirrhosis was confirmed by histopathological 
analysis. These results indicate that the BDL model induces anxiogenic results, possibly related to changes in 
the activation of anxiety-mediating circuitries and to increases in ammonia plasma levels.
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INTRODUCTION
Liver cirrhosis is a chronic disease, commonly 
caused by alcohol abuse or hepatitis C, which may 
be defined as the histological development of rege-
nerative nodules encircled by fibrous bands as a 
reaction to liver injury (Schuppan and Afdhal 2008). 
Some of the clinical outcomes of cirrhosis: decreased 
liver function, increased portal hypertension and 
hepatocellular carcinoma. Circulatory abnormalities, 
i.e. splanchnic vasodilation, vasoconstriction and 
kidney hypoperfusion, retention of salt/water and 
augmented cardiac output, which also accompany 
cirrhosis, are closely related to the vascular hepatic 
alterations and portal hypertension (Schuppan 
and Afdhal 2008). Liver cirrhosis is one of the 
major health problems in the Western world. 
The disease demands expensive treatments and 
presents high mortality rates (Schuppan and Afdhal 
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2008, Weissenborn et al. 1997). The prevalence 
of liver cirrhosis is approximately 35 per 100,000 
of the population overall, with an incidence of 
approximately 5 per 100,000 per year. It is the 12th 
leading cause of hospitalizations and death in the 
US (Kim et al. 2000).
One of the main complications of liver cirrhosis 
is hepatic encephalopathy (HE) (Butterworth 
2003, Garcia-Tsao 2001). This term has been used 
to identify a broad variety of neuropsychiatric 
abnormalities (i.e., anxiety and depression symptoms, 
altered sleep patterns and cognitive and psychomotor 
impairments), which can occur in cirrhotic patients, 
after exclusion of other neurological and/or metabolic 
causes (Butterworth 2003, Sunmonu et al. 2012). 
HE occurs in nearly 30–45% of patients with liver 
cirrhosis (Khungar and Poordad 2012). When HE 
is severe, patients may develop variable degrees of 
confusion and even coma (Ferenci et al. 1998).
The pathogenesis of HE is largely unknown 
(Gerber and Schomerus 2000), although some 
theories have been proposed. It is known 
that inadequate hepatic detoxification causes 
accumulation of circulating gut-derived toxins of 
nitrogenous compounds, in particular ammonia 
(Phongsamran et al. 2010). Peripheral glutamine 
synthetase may function as a substitute ammonia 
detoxification pathway in patients with reduced 
ability for detoxification of ammonia into urea. 
Glutamine synthesis also occurs in astrocytes 
(Butterworth 2003, Vaquero et al. 2003). It has been 
proposed that this could cause astrocyte swelling and 
possibly be responsible for some of the neurological 
abnormalities present in HE (Phongsamran et 
al. 2010). It is also suggested that inflammatory 
cytokines play a fundamental role in the pathogenesis 
of HE (Phongsamran et al. 2010). Additionally, 
alterations of some neurotransmitter systems, such 
as glutamate, GABA, serotonin, catecholamines and 
endogenous opioids, have been implicated in the 
ethiopathogeny of HE (Albrecht and Jones 1999, 
Butterworth 2003). Apart from these few “working 
hypotheses”, however, the neurobiological substrates 
that may be responsible for the clinical manifestations 
of HE are largely unclear.
The purpose of the present study was to 
investigate anxiety and motor behavior in bile 
duct-ligated (BDL) rats, an experimental model 
of cirrhosis. The validity of the BDL model for 
studying behavioral and biochemical alterations 
of liver cirrhosis has been well documented 
(Assimakopoulos and Vagianos 2009, Blei and 
Córdoba 2001). The model causes jaundice 
and impairment of liver function, and also 
induces fibrosis, portal hypertension, portal-
systemic shunting, and inflammatory activation 
(Assimakopoulos and Vagianos 2009, Blei and 
Córdoba 2001).
For the evaluation of anxious behavior, BDL 
and sham animals were tested in the elevated 
plus-maze (EPM) (Cruz et al. 1994, Pellow et al. 
1985). Although increases in anxiety are frequently 
described for HE patients, in animal models, 
anxiety-related effects are difficult to interpret due 
to confounding psychomotor impairments. Thus, to 
separate anxiety from locomotor activity assessment, 
three different indices of motor activity (Cruz et al. 
1994, Royce 1977) were also obtained from the 
same animals: the number of entries into the closed 
arms of the EPM, the number of lines crossed and 
the frequency of rearings in an open field.
After the behavioral tests, analysis of Fos 
protein immunoreactivity (Fos-ir) was used to 
better understand the neurobiological alterations 
induced in BDL animals. For both experimental 
groups, plasma levels of ammonia were quantified 
and histopathological analysis of the liver was 
performed at the end of the experiments.
MATERIALS AND METHODS
SUBJECTS
Male Wistar rats (Federal University of São Paulo, 
CEDEME, Brazil), weighing approximately 280 g, 
were housed in groups of 5-6 per cage. After surgery, 
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animals were housed in pairs in Plexiglas-walled 
cages until testing on the 21st day after surgery. 
Room temperature was controlled (22 ± 1° C) and 
a light-dark cycle was maintained on a 12-h on-
off cycle (lights on at 7 am). Food and water were 
available ad libitum throughout the experiments. 
The present study was approved by the Ethical 
Committee for Animal Research of the Federal 
University of São Paulo (UNIFESP) under the 
number 1800/09 and was performed in compliance 
with the recommendations of the SBNeC (Brazilian 
Society of Neuroscience and Behavior), which are 
based on the US National Institutes of Health Guide 
for Care and Use of Laboratory Animals.
SURGERY - BILE DUCT-LIGATION
One day after their arrival, rats were anaesthetized 
with an IP injection of ketamine hydrochloride 
(80 mg/kg; Agribrands, Brazil) and xylazine (10 
mg/kg; Agribrands, Brazil) and laparotomy was 
performed. The common bile duct was isolated and 
tied in two locations: in the proximal portion and in 
the distal part of the duct. The ligatures were then 
tightened and the incision sutured. Sham-animals 
were subjected to the same surgical procedure, 
except the bile duct was not ligated.
After surgery, all animals were submitted to 
anti-inflammatory and analgesic care. They were 
treated orally with two drops of dipyrone (500 
mg/mL, Novalgina, Safoni Aventis, Brazil), and 
received a solution of water and sucrose (10%) 
plus acetylsalicylic acid (0.2 mg/ml, Aspirin, 
Bayer, Brazil), which they were allowed to drink 
ad libitum for a period of 24 hours.
APPARATUS
Elevated plus-maze (EPM)
The EPM was made of wood and had four arms of 
equal dimensions (50 x 10 cm). Two arms, enclosed 
by 40 cm high walls, were perpendicular to two 
opposed open arms. To avoid falls, the open arms 
were surrounded by a 1 cm high Plexiglas rim. The 
four arms delimited a central area of 10 cm2. The 
whole apparatus was elevated 50 cm above the floor.
Open field
The open field test was performed in a round arena 
(60 x 60 cm), with the floor divided into 12 parts, 
and walls 50 cm high.
Luminosity at the level of the maze arms and 
at the center of the open field was 60 lux. The 
experimental sessions were recorded on DVDs 
by a vertically mounted videocamera, linked to a 
monitor placed in an adjacent room. An observer 
blind to the treatment conditions, later analyzed the 
recorded experimental sessions.
BEHAVIORAL ANALYSIS
On the 21st day after surgery, sham and BDL (N = 
9 per treatment group) animals were submitted to 
the behavioral tests. Animals were tested on the 21st 
day after surgery since previous studies showed that 
3 to 4 weeks after bile-duct ligation the induction of 
a cirrhotic state is obtained (see Kontouras et al. 
1984, Pereira et al. 2008).
For the behavioral tests, rats were taken in 
their home cages to the experimental room and 
individually placed in the center of the EPM. They 
were then allowed to freely explore the maze for 
5 min. The standard measures (number of entries 
into open and closed arms, and time spent in open 
and closed arms) (see references Cruz et al. 1994, 
Pellow et al. 1985) were recorded for posterior 
analysis. After quantification, measurements of 
number of entries and time spent in open arms were 
transformed into percentages (percentage of entries 
in open arms = [number of entries in open arms/
total number of entries] x 100; percentage of time in 
open arms = [time in open arms/total time] x 100). 
It has been previously shown (Cruz et al. 1994) that 
the two critical measurements that represent the 
reverse of anxiety are: the percentage of open arm 
entries and the percentage of time spent in open 
arms. On the other hand, the critical measurement 
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for locomotor activity seems to be the total number 
of closed arm entries (Cruz et al. 1994).
Immediately after the tests with the EPM, 
animals were placed in the center of the open field 
and also allowed to freely explore for 5 min for 
posterior measurements of the total number of lines 
crossed and frequency of rearings.
After each experimental session with the EPM 
or open field, each apparatus was cleaned with a 
solution of 20% ethanol and dried.
MEASUREMENTS OF AMMONIA PLASMA LEVELS
On the morning of the 22nd day, animals were 
anesthetized with ketamine/xylazine as described 
above and blood was collected from the left 
ventricle after thoracic aperture, before perfusion, 
placed in heparinized tubes and centrifuged for 
15 min at 1500 rpm, at 4° C. Plasma ammonia 
concentrations were analyzed via endpoint 
colorimetric assay (Vitros 750, Johnson & Johnson 
Clinical Diagnostics, USA). Briefly, ammonium 
ions are converted to gaseous ammonia and pass 
through a semipermeable membrane layer before 
reacting with bromophenol blue.
FOS PROTEIN IMMUNOREACTIVITY (FOS-IR)
Immediately after blood collection, six animals 
from each group were perfused with ≈100 ml of 
0.9% saline for approximately 1 min, followed 
by 500–700 ml of 4% formaldehyde (from 
paraformaldehyde heated to 60–65° C) and H2O 
at 4° C, pH 9.5, for approximately 25 min. Their 
brains were post-fixed for 1 h in the same fixative 
and were kept in a buffer containing 20% sucrose 
overnight at 4° C. Regularly spaced series (5×1-
in-5) of 30 µm-thick frozen sections were cut in 
the frontal plane, collected in ethylene glycol-
based cryoprotectant solution and stored at −20° 
C for later determination of Fos-ir. Labeled 
neurons were identified using a polyclonal anti-
plasma raised in rabbits against synthetic human 
Fos (anti-Fos, 1:20,000; Oncogene, USA). 
Immunohistochemistry was performed using a 
conventional avidin–biotin immunoperoxidase 
protocol (Hsu and Raine 1981) and Vectastain Elite 
reagents (Vector Laboratories, USA). Tissue was 
pretreated with hydrogen peroxide (0.3%; Sigma, 
USA) before addition of the primary antibody to 
squelch endogenous peroxidase activity in the 
tissue. The reaction with diaminobenzidine-DAB 
(0.05%; Sigma, USA) was amplified using nickel 
ammonium sulfate and the sections were then 
mounted on gelatin-coated slides.
DATA COLLECTION AND ANALYSIS
We quantified Fos-ir neurons in sections, under 
bright-field illumination using the Image-Pro Plus 
software (Media Cybernetics, USA), having as 
reference the following AP coordinates (Paxinos 
and Watson 2008): amygdala = bregma -2.92; 
dorso and ventromedial hypothalamic nuclei 
= bregma -2.92; paraventricular nucleus of the 
hypothalamus and anterior hypothalamic area 
(central part) = bregma -1.80; pre-frontal cortex 
= bregma +1.68; lateral septal nucleus = bregma 
+1.68; bed nucleus of the stria terminalis (medial 
and lateral divisions) = bregma -0.7; hippocampus 
= bregma - 2,80. Sections were analyzed by an 
observer blind to the treatment conditions. Cells 
were considered Fos-ir if their nuclei contained 
dark, punctate gray-black immunolabeling, 
and were counted using constant minimum and 
maximum OD and object size criteria, which were 
validated by means of visual counts.
HISTOPATHOLOGICAL ANALYSIS
To confirm the cirrhotic state, liver fragments from 
the two groups were collected for histopathological 
examinations. The samples were fixed in 10% 
buffered formalin, routinely processed and embedded 
in paraplast (Histosec, Merck, USA). Sections of 5-7 
µm were stained with hematoxylin and eosin (H.E., 
Merck, USA) and observed and photographed using 
a light microscope (Axio Observer D1, Zeiss, USA).
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STATISTICAL ANALYSIS
Unpaired Student-T test was used to analyze 
behavioral data, ammonia plasma levels and Fos-ir. 
A value of p < 0.05 was considered significant.
RESULTS
ELEVATED PLUS-MAZE (EPM) AND OPEN FIELD
Figure 1 shows the percentage of entries (left panel) 
and time (right panel) spent in the open arms of the 
EPM. The unpaired Student T-test indicated that 
the BDL group showed a significant decrease in the 
percentage of entries (T (9.19) = 11.76; P < 0.001) 
and time spent in the open arms of the EPM (T (16) 
= 2.99; P = 0.009).
Table I shows the number of entries into the 
closed arms of the EPM, the total number of lines 
crossed and the frequency of rearings in the open 
field. No significant differences were observed 
between the two groups for any of the parameters. 
Nevertheless, regarding the number of lines crossed 
the statistical result obtained, was close to statistical 
significance (T (16) = 1.89; P = 0.08).
FOS IMMUNOREACTIVITY (FOS-IR)
Table II shows Fos-ir for the different anxiety-
related regions analyzed. The unpaired Student-T 
test showed that for the intermediate lateral septal 
nucleus (T(5.26) = 3.39; P = 0.018) (Fig 2, upper 
Figure 1 - Percentage (mean ± SEM) of entries (left panel) and time spent (right panel) in 
the open arms of the elevated plus-maze by sham and bile duct-ligated (BDL) animals. 
N = 9 per treatment group. *P<0.05 with respect to the sham group (unpaired Student T-test).
TABLE I
Number (mean ± SEM) of closed arms entries in the 
elevated plus-maze and crossings and rearings in the open 
field by sham and bile duct-ligated (BDL) animals.
Treatments Closed Arms Entries Crossings Rearings 
Sham 9.67 ± 0.94 35.44 ± 5.62 13.00 ± 1.69 
BDL 6.78 ± 1.46 22.78 ± 3.63 10.67 ± 1.89 
panel) and medial amygdalar nucleus (T(5.44) 
= 3.29; P = 0.019) (Fig 2, lower panel) the BDL 
group showed significant decreases in Fos-ir when 
compared to the sham group (P < 0.05). There were 
no significant differences between BDL and sham 
animals for the other analyzed areas (P > 0.05).
AMMONIA PLASMA LEVELS
Figure 3 shows ammonia levels on the 22nd day 
after surgery for the two experimental groups. The 
unpaired Student-T test indicated that the BDL 
group presented significant increases in ammonia 
plasma levels when compared to sham animals 
(T(9.35) =-6.25; P < 0.001).
HISTOPATHOLOGICAL ANALYSIS
Figure 4 shows liver photomicrographs from 
the two experimental groups. Histopathological 
analysis showed that the livers of BDL animals 
were marked by disorganization of the lobular 
cytoarchitecture, with proliferation of portal and 
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Figure 2 - Photomicrographs of Fos-immunoreactive cells (dark spots) in coronal sections through 
brain regions with significant decreases in Fos immunoreactivity after bile duct-ligation. Upper 
panel: Intermediate part of the lateral septal nucleus; Lower panel: Medial amygdalar nucleus. N=6 
per treatment group. (*) lateral ventricle; (**) optic tract. Scale Bars: 100 and 200µm.
Structures Sham BDL 
Pre-frontal Cortex 59.67 ± 13.08 58.33 ± 10.13
CA1 and CA2 (hippocampus) 7.50 ± 5.74 0.80 ± 0.49
CA3 (hippocampus) 4.00 ± 2.31 1.20 ± 0.58
Dentate Gyrus (hippocampus) 17.83 ± 7.96 3.60 ± 1.75
Dorsolateral Septum 6.50 ± 2.81 3.60 ± 1.91
Intermediate Lateral Septum 48.33 ± 12.19 6.50 ± 1.96*
Ventrolateral Septum 57.50 ± 24.00 25.33 ± 5.74
Bed Nucleus Stria Terminalis 3.17 ± 1.22 2.26 ± 8.67
Basolateral Amygdala 12.33 ± 3.97 4.33 ± 1.65
Basomedial Amygdala 13.67 ± 8.13 5.00 ± 2.89
Lateral Amygdala 9.50 ± 4.32 8.33 ± 2.03
Medial Amygdala 41.83 ± 10.67 6.00 ± 2.25*
Central Amygdala 16.00 ± 8.78 16.67 ± 6.81
Dorsomedial Hypothalamus 87.20 ± 37.23 14.17 ± 2.56
Ventromedial Hypothalamus 31.33 ± 11.79 21.83 ± 5.88
Anterior Hypothalamus 70.83 ± 15.82 48.17 ± 11.11
Paraventricular Hypothalamus 44.33 ± 11.59 40.00 ± 9.88
TABLE II
Number (mean ± SEM) of Fos immunoreactive cells 
in pre-determined areas of anxiety-related regions of 
sham and bile duct-ligated (BDL). 
*P < 0.05 with respect to sham animals (Unpaired Student-T test). 
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periportal biliary ductules, dilated portal spaces and 
areas of polymorphonuclear leukocyte infiltration. 
Fibrosis and hepatocytes in the process of cell death 
were also observed. None of these morphological 
alterations were observed in the sham group.
Figure 4 - Photomicrographs of liver sections of sham (A) and bile-duct ligated animals (BDL) 
(B-D). Livers of BDL animals presented disorganization of the lobular cytoarchitecture (B), with 
proliferation of portal and periportal biliary ductules (C,*) and areas of fibrosis (D, **), among 
strands of degenerating hepatocytes. None of these pathological alterations were observed in sham 
animals (A). Scale Bar: 100 µm.
Figure 3 - Ammonia plasma levels (µmol/l) in sham and bile 
duct-ligated (BDL) animals. N = 5 (sham) and 7 (BDL). *P<0.05 
with respect to the sham group (unpaired Student T-test).
DISCUSSION
The results of the present study showed that BDL 
animals exhibited a significant decrease in the 
percentage of entries and time spent in the open 
arms of the EPM, without significant alterations 
in motor activity. These results are indicative of 
an increase in anxiety. BDL animals also showed 
a significant decrease in Fos-ir in the intermediate 
lateral septal nucleus and medial amygdalar 
nucleus. These neurobiological changes were 
accompanied by higher ammonia plasma levels and 
histopathological alterations of the liver tissue, thus 
confirming that the bile duct-ligation procedure 
was efficient in inducing liver cirrhosis.
The few studies that have verified anxiety-
related effects in BDL animals are contradictory, 
in part due to the interference of locomotor 
parameters. It has been shown, for instance, that the 
distance traveled in the center zone of an arena was 
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decreased in BDL rats (Leke et al. 2012). Usually, 
this pattern of behavior is interpreted as avoidance 
of the open area, and suggests anxiety behavior. 
Nevertheless, in the same study, measurements in 
the EPM did not show increases in anxiety. It is 
worth mentioning, however, that the indices that 
these authors used to evaluate anxiety in the EPM 
(percentage of entries and time spent in the closed 
arms) are not the ones traditionally used. Since the 
open space is the aversive stimulus in the EPM 
model, anxiety behavior is related to a decrease in 
the percentage of entries and time spent in the open 
arms (Cruz et al. 1994). In fact, closed arm entries 
correlate positively with locomotor activity and not 
with anxiety (Cruz et al. 1994). Thus, the results 
of this particular study do not allow the conclusion 
that no anxiety-related effects were found in BDL 
animals. Furthermore, in another study (Ahboucha 
et al. 2008) performed with rats with portacaval 
anastomosis tested in the EPM, no anxiety-related 
effects were found, but deficits in the animals’ 
motor behavior were observed, thus compromising 
any conclusion regarding anxiety parameters.
On the other hand, the anxiogenic effects 
observed were consistent with clinical descriptions 
of HE patients (Butterworth 2003, Sakamoto et al. 
2012). According to the West Haven scale (WHS) 
(for a review see Sakamoto et al. 2012), which 
measures stages of hepatic encephalopathy, anxiety 
symptoms are present in stage 2 HE patients, 
indicating moderate impairment. In addition, 
another instrument largely used to diagnose HE, 
the Hepatic Encephalopathy Scoring Algorithm 
(HESA) - which combines clinical examination 
with neuropsychological tests when determining 
HE grades on a scale from 0-4 (absence-severe 
HE) - includes anxiety symptoms as clinical 
manifestations of stage 1. Thus, in our present 
study, the BDL model was effective in replicating 
this important symptom of HE.
It is noteworthy that both scales also include 
psychomotor impairment (slow responses, lethargy) 
as symptoms present in HE. According to the 
HESA, psychomotor impairment would describe 
a more severe grade of encephalopathy (stage 2 
HE). Although in some of the studies conducted 
with different animal models of HE, decreases in 
locomotor activity were observed (Ahboucha et 
al. 2008, Leke et al. 2012), in others, no motor 
alterations were found (Sergeeva et al. 2005). In 
fact, some studies have suggested that depending 
on the test used to measure motor activity, deficits 
may or may not be obtained. For instance, in a 
study also performed with the BDL model, Jover 
and coworkers (Jover et al. 2006) showed that 
although the rats presented a mild impairment of 
motor coordination in the rotarod, no significant 
differences were observed in the beam-walking test. 
If taken together, these clinical and experimental 
observations seem to suggest that depending on the 
degree of severity of the state of HE induced, and 
(possibly) on the test used to measure locomotion, 
motor deficits may or may not be detected.
Analysis of Fos-ir showed decreases in the 
pattern of activity of most brain regions analyzed, 
and in particular in the intermediate part of the lateral 
septal nucleus and in the medial amygdalar nucleus. 
It is important to emphasize, however, that the 
immunohistochemical analysis was performed 24 h 
after the behavioral tests. Therefore, these results are 
indicative of changes induced by the BDL model, 
and not by the anxiogenic stimulus itself.
Nevertheless, it is worth noting that both the 
lateral septum and the medial amygdala are regions 
that have traditionally been related to the modulation 
of anxiety. Several authors have emphasized the 
important role played by the lateral septum in the 
control of anxiety. Whether the nature of this control 
is inhibitory (Thomas 1988, Yadin et al. 1993) or 
facilitatory (Treit and Menard 2000) is still a matter 
of debate. As previously pointed out (de Andrade et 
al. 2012, Diniz et al. 2013) the septal region, together 
with the hippocampus, is one of the main structures of 
the so-called “Behavioral Inhibition System” (Gray 
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and McNaughton 2001, Gray 1987, McNaughton 
and Corr 2004), activated when the animal is faced 
with a threat which involves approach-avoidance 
conflict. In this sense it is interesting to point out 
that increases in the anxious behavior in the EPM 
are accompanied by a decrease in risk-assessment 
(Cruz et al. 1994), which typically occurs in 
approach-avoidance conflict situations (Gray 1987, 
McNaughton and Corr 2004).
The medial amygdalar nucleus is functionally 
distinct from other amygdala nuclei (Canteras 
2002, Maras and Petrulis 2010). It is known as the 
“vomeronasal amygdala” since it receives pheromone 
cues from the accessory olfactory bulb and olfatory 
inputs from the cortical amygdala (Kang et al. 2009, 
Kevetter and Winans 1981). These chemosignals 
bring information from opposite and same-sex 
individuals, thus providing the structure with critical 
information for the modulation of reproductive, 
social and defensive behaviors (Niimi et al. 2012). 
Indeed, a number of previous studies from our and 
other research groups have indicated the important 
role played by the medial amygdalar nucleus in the 
regulation of defense and anxiety-related responses 
(Diniz et al. 2013, Ferenci et al. 1998, Herdade et 
al. 2006, Ma and Morilak 2005). Although the 
majority of these studies measure increases in Fos-ir 
in response to anxiogenic stimuli (and in this sense 
measure state anxiety), studies directed towards the 
investigation of trait anxiety and thus performed with 
rat lines selectively bred for high anxiety-related 
behavior (see for instance Muigg et al. 2008) show 
an attenuated c-Fos response to repeated conditioned 
stimulus presentations in the frontal cortices, as well 
as in different amygdala nuclei, with the exception 
of the central amygdala. It is interesting to point 
out that this last observation also goes in the same 
direction as the results obtained in the present study.
Although the mechanisms responsible for the 
decreases in Fos-ir still need to be elucidated, one of 
the hypotheses concerning HE etiopathogeny suggests 
that the behavioral deficits induced by this condition 
are possibly related to alterations in glutamate-
mediated neurotransmission. A key role for ammonia 
in the pathogenesis of HE has been extensively 
supported by both clinical and experimental data 
(Gerber and Schomerus 2000, Vaquero et al. 2003, 
Jover et al. 2006, Khungar and Poordad, 2012). 
Ammonia crosses the blood-brain barrier mainly 
through the transendothelial route, using potassium 
channels and transporters or by replacing other 
cations with comparable hydrated radius (for a review 
see Skowrońska and Albrecht 2012). In the brain, the 
synthesis of glutamate is linked to a substrate cycle 
involving glutamine metabolism (Bak et al. 2006) 
in neurons and astrocytes. As previously mentioned 
(Phongsamran et al. 2010), glutamine synthesis is 
altered in response to increases in ammonia levels. 
Reduced glutamate levels have consistently been 
observed in brain homogenates from rats with acute 
liver failure (Hilgier and Olson 1994) and from 
patients who died from hepatic coma (Lavoie et al. 
1987). Thus, one possibility (to be further evaluated) 
is that the increases in ammonia levels are related 
to decreases in glutamate neurotransmission and, 
consequently, to the decreases in Fos-ir observed.
In conclusion, the results of the present study 
indicate that the BDL model induces anxiety-like 
behavior and decreases in the activation of two 
anxiety-mediating brain regions, the intermediate 
part of the lateral septal nucleus and the medial 
amygdalar nucleus, which is possibly related to 
the increases in ammonia plasma levels detected. 
Nevertheless, if and how increases in ammonia 
plasma levels may lead to anxious behavior and 
decreases in the activation of anxiety-related 
circuits still deserves investigation.
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RESUMO
A Encefalopatia hepática (HE) engloba uma 
variedade de sintomas neuropsiquiátricos, incluindo 
ansiedade e disfunção psicomotora. Embora seja uma 
complicação frequente da cirrose hepática, os substratos 
neurobiológicos responsáveis por suas manifestações 
clínicas são em grande parte desconhecidos. No 
presente estudo, ratos Wistar machos foram submetidos 
ao procedimento cirúrgico de ligação e secção do ducto 
biliar (BDL; bile-duct ligation), para indução da cirrose 
hepática e, no 21º dia após a cirurgia, submetidos aos testes 
comportamentais no labirinto em cruz elevado (LCE) e 
campo aberto para avaliação da ansiedade e atividade 
locomotora. A análise da imunorreatividade à proteína 
Fos (Fos-ir) foi utilizada para melhor compreender as 
alterações neurobiológicas presentes nos animais do 
grupo BDL. Foi realizada a quantificação da concentração 
de amônia plasmática e análise histopatológica dos 
fígados. Os ratos do grupo BDL mostraram diminuição 
significativa na porcentagem de entradas e tempo 
gasto nos braços abertos do LCE, caracterizando efeito 
ansiogênico. Estes animais também apresentaram 
redução significativa na Fos-ir no núcleo septal lateral e 
núcleo medial da amígdala. A concentração plasmática 
de amônia foi significativamente mais elevada que a do 
grupo sham e o diagnóstico de cirrose foi confirmado 
por análise histopatológica. Estes resultados indicam 
que o modelo de HE induzido por BDL induz efeito 
ansiogênico possivelmente relacionado à ativação de 
circuitos mediadores da ansiedade e à hiperamonemia.
Palavras-chave: ansiedade, ligação do ducto biliar, 
encefalopatia hepática, atividade locomotora.
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